Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 491

1.

A network analysis to identify pathophysiological pathways distinguishing ischaemic from non-ischaemic heart failure.

Sama IE, Woolley RJ, Nauta JF, Romaine SPR, Tromp J, Ter Maaten JM, van der Meer P, Lam CSP, Samani NJ, Ng LL, Metra M, Dickstein K, Anker SD, Zannad F, Lang CC, Cleland JGF, van Veldhuisen DJ, Hillege HL, Voors AA.

Eur J Heart Fail. 2020 Apr 3. doi: 10.1002/ejhf.1811. [Epub ahead of print]

PMID:
32243695
2.

Effects of Sacubitril/Valsartan on N-Terminal Pro-B-Type Natriuretic Peptide in Heart Failure With Preserved Ejection Fraction.

Cunningham JW, Vaduganathan M, Claggett BL, Zile MR, Anand IS, Packer M, Zannad F, Lam CSP, Janssens S, Jhund PS, Kober L, Rouleau J, Shah SJ, Chopra VK, Shi VC, Lefkowitz MP, Prescott MF, Pfeffer MA, McMurray JJV, Solomon SD.

JACC Heart Fail. 2020 Mar 26. pii: S2213-1779(20)30146-3. doi: 10.1016/j.jchf.2020.03.002. [Epub ahead of print]

PMID:
32241619
3.

Therapeutic approaches in heart failure with preserved ejection fraction: past, present, and future.

Wintrich J, Kindermann I, Ukena C, Selejan S, Werner C, Maack C, Laufs U, Tschöpe C, Anker SD, Lam CSP, Voors AA, Böhm M.

Clin Res Cardiol. 2020 Mar 31. doi: 10.1007/s00392-020-01633-w. [Epub ahead of print] Review.

PMID:
32236720
4.

Time to rename the middle child of heart failure: heart failure with mildly reduced ejection fraction.

Lam CSP, Voors AA, Piotr P, McMurray JJV, Solomon SD.

Eur Heart J. 2020 Mar 30. pii: ehaa158. doi: 10.1093/eurheartj/ehaa158. [Epub ahead of print] No abstract available.

PMID:
32227233
5.

Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction.

Armstrong PW, Pieske B, Anstrom KJ, Ezekowitz J, Hernandez AF, Butler J, Lam CSP, Ponikowski P, Voors AA, Jia G, McNulty SE, Patel MJ, Roessig L, Koglin J, O'Connor CM; VICTORIA Study Group.

N Engl J Med. 2020 Mar 28. doi: 10.1056/NEJMoa1915928. [Epub ahead of print]

PMID:
32222134
6.

Evaluation of high-sensitivity C-reactive protein and uric acid in vericiguat-treated patients with heart failure with reduced ejection fraction.

Kramer F, Voss S, Roessig L, Igl BW, Butler J, Lam CSP, Maggioni AP, Shah SJ, Pieske B.

Eur J Heart Fail. 2020 Mar 25. doi: 10.1002/ejhf.1787. [Epub ahead of print]

PMID:
32216011
7.

QRS duration and cardiovascular mortality in Asian patients with heart failure and preserved and reduced ejection fraction.

Yap J, Keh YS, Shen T, Lam CSP, Chia SY, Jaufeerally FR, Ong W, Sim D, Ching CK.

Cardiol J. 2020 Mar 24. doi: 10.5603/CJ.a2020.0041. [Epub ahead of print]

8.

Systolic Blood Pressure in Heart Failure With Preserved Ejection Fraction Treated With Sacubitril/Valsartan.

Selvaraj S, Claggett BL, Böhm M, Anker SD, Vaduganathan M, Zannad F, Pieske B, Lam CSP, Anand IS, Shi VC, Lefkowitz MP, McMurray JJV, Solomon SD.

J Am Coll Cardiol. 2020 Mar 11. pii: S0735-1097(20)30518-0. doi: 10.1016/j.jacc.2020.02.009. [Epub ahead of print]

PMID:
32192799
9.

Natriuretic Peptide-Based Inclusion Criteria in a Heart Failure Clinical Trial: Insights From COMMANDER HF.

Cunningham JW, Ferreira JP, Deng H, Anker SD, Byra WM, Cleland JGF, Gheorghiade M, Lam CSP, La Police D, Mehra MR, Neaton JD, Spiro TE, van Veldhuisen DJ, Greenberg B, Zannad F.

JACC Heart Fail. 2020 Mar 3. pii: S2213-1779(20)30018-4. doi: 10.1016/j.jchf.2019.12.009. [Epub ahead of print]

PMID:
32171760
10.

How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC).

Pieske B, Tschöpe C, de Boer RA, Fraser AG, Anker SD, Donal E, Edelmann F, Fu M, Guazzi M, Lam CSP, Lancellotti P, Melenovsky V, Morris DA, Nagel E, Pieske-Kraigher E, Ponikowski P, Solomon SD, Vasan RS, Rutten FH, Voors AA, Ruschitzka F, Paulus WJ, Seferovic P, Filippatos G.

Eur J Heart Fail. 2020 Mar;22(3):391-412. doi: 10.1002/ejhf.1741. Epub 2020 Mar 5.

PMID:
32133741
11.

The association of long-term outcome and biological sex in patients with acute heart failure from different geographic regions.

Motiejūnaitė J, Akiyama E, Cohen-Solal A, Maggioni AP, Mueller C, Choi DJ, Kavoliūnienė A, Čelutkienė J, Parenica J, Lassus J, Kajimoto K, Sato N, Miró Ò, Peacock WF, Matsue Y, Voors AA, Lam CSP, Ezekowitz JA, Ahmed A, Fonarow GC, Gayat E, Regitz-Zagrosek V, Mebazaa A.

Eur Heart J. 2020 Apr 1;41(13):1357-1364. doi: 10.1093/eurheartj/ehaa071.

PMID:
32125360
12.

Interactions between left ventricular ejection fraction, sex and effect of neurohumoral modulators in heart failure.

Dewan P, Jackson A, Lam CSP, Pfeffer MA, Zannad F, Pitt B, Solomon SD, McMurray JJV.

Eur J Heart Fail. 2020 Mar 2. doi: 10.1002/ejhf.1776. [Epub ahead of print] No abstract available.

PMID:
32115864
13.

Post-discharge prognosis of patients admitted to hospital for heart failure by world region, and national level of income and income disparity (REPORT-HF): a cohort study.

Tromp J, Bamadhaj S, Cleland JGF, Angermann CE, Dahlstrom U, Ouwerkerk W, Tay WT, Dickstein K, Ertl G, Hassanein M, Perrone SV, Ghadanfar M, Schweizer A, Obergfell A, Lam CSP, Filippatos G, Collins SP.

Lancet Glob Health. 2020 Mar;8(3):e411-e422. doi: 10.1016/S2214-109X(20)30004-8.

14.

Sex differences in mineralocorticoid receptor antagonist trials: a pooled analysis of three large clinical trials.

Rossello X, Ferreira JP, Pocock SJ, McMurray JJV, Solomon SD, Lam CSP, Girerd N, Pitt B, Rossignol P, Zannad F.

Eur J Heart Fail. 2020 Feb 19. doi: 10.1002/ejhf.1740. [Epub ahead of print]

PMID:
32077220
15.

Sex Differences in Primary and Secondary Prevention of Cardiovascular Disease in China.

Xia S, Du X, Guo L, Du J, Arnott C, Lam CSP, Huffman MD, Arima H, Yuan Y, Zheng Y, Wu S, Guang X, Zhou X, Lin H, Cheng X, Anderson CS, Dong J, Ma C.

Circulation. 2020 Feb 18;141(7):530-539. doi: 10.1161/CIRCULATIONAHA.119.043731. Epub 2020 Feb 17.

PMID:
32065775
16.

Women's Participation in Cardiovascular Clinical Trials From 2010 to 2017.

Jin X, Chandramouli C, Allocco B, Gong E, Lam CSP, Yan LL.

Circulation. 2020 Feb 18;141(7):540-548. doi: 10.1161/CIRCULATIONAHA.119.043594. Epub 2020 Feb 17.

PMID:
32065763
17.

Risk Factors for Heart Failure: 20-Year Population-Based Trends by Sex, Socioeconomic Status, and Ethnicity.

Lawson CA, Zaccardi F, Squire I, Okhai H, Davies M, Huang W, Mamas M, Lam CSP, Khunti K, Kadam UT.

Circ Heart Fail. 2020 Feb;13(2):e006472. doi: 10.1161/CIRCHEARTFAILURE.119.006472. Epub 2020 Feb 14.

PMID:
32059630
18.

Distinct Pathological Pathways in Patients With Heart Failure and Diabetes.

Tromp J, Voors AA, Sharma A, Ferreira JP, Ouwerkerk W, Hillege HL, Gomez KA, Dickstein K, Anker SD, Metra M, Lang CC, Ng LL, van der Harst P, van Veldhuisen DJ, van der Meer P, Lam CSP, Zannad F, Sama IE.

JACC Heart Fail. 2020 Mar;8(3):234-242. doi: 10.1016/j.jchf.2019.11.005. Epub 2020 Feb 5.

PMID:
32035890
19.

Integrating natriuretic peptides and diastolic dysfunction to predict adverse events in high-risk asymptomatic subjects.

Gori M, Lam CS, D'Elia E, Iorio AM, Calabrese A, Canova P, Cioffi G, De Maria R, Ghirardi A, Iacovoni A, Grosu A, Fontana A, Ferrari P, Parati G, Gavazzi A, Senni M.

Eur J Prev Cardiol. 2020 Feb 3:2047487319899618. doi: 10.1177/2047487319899618. [Epub ahead of print]

PMID:
32013597
20.

Sodium-Glucose Cotransporter 2 Inhibition for the Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis.

Arnott C, Li Q, Kang A, Neuen BL, Bompoint S, Lam CSP, Rodgers A, Mahaffey KW, Cannon CP, Perkovic V, Jardine MJ, Neal B.

J Am Heart Assoc. 2020 Feb 4;9(3):e014908. doi: 10.1161/JAHA.119.014908. Epub 2020 Jan 29.

21.

Circulating neuregulin1-β in heart failure with preserved and reduced left ventricular ejection fraction.

Hage C, Wärdell E, Linde C, Donal E, Lam CSP, Daubert C, Lund LH, Månsson-Broberg A.

ESC Heart Fail. 2020 Jan 24. doi: 10.1002/ehf2.12615. [Epub ahead of print]

22.

Left atrial function in heart failure with preserved ejection fraction: a systematic review and meta-analysis.

Khan MS, Memon MM, Murad MH, Vaduganathan M, Greene SJ, Hall M, Triposkiadis F, Lam CSP, Shah AM, Butler J, Shah SJ.

Eur J Heart Fail. 2020 Mar;22(3):472-485. doi: 10.1002/ejhf.1643. Epub 2020 Jan 9.

PMID:
31919960
23.

Genetic risk and atrial fibrillation in patients with heart failure.

Kloosterman M, Santema BT, Roselli C, Nelson CP, Koekemoer A, Romaine SPR, Van Gelder IC, Lam CSP, Artola VA, Lang CC, Ng LL, Metra M, Anker S, Filippatos G, Dickstein K, Ponikowski P, van der Harst P, van der Meer P, van Veldhuisen DJ, Benjamin EJ, Voors AA, Samani NJ, Rienstra M.

Eur J Heart Fail. 2020 Mar;22(3):519-527. doi: 10.1002/ejhf.1735. Epub 2020 Jan 9.

PMID:
31919934
24.

Circulating levels and prognostic value of soluble ST2 in heart failure are less influenced by age than N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T.

Aimo A, Januzzi JL Jr, Vergaro G, Richards AM, Lam CSP, Latini R, Anand IS, Cohn JN, Ueland T, Gullestad L, Aukrust P, Brunner-La Rocca HP, Bayes-Genis A, Lupón J, de Boer RA, Takeishi Y, Egstrup M, Gustafsson I, Gaggin HK, Eggers KM, Huber K, Gamble GD, Ling LH, Leong KTG, Yeo PSD, Ong HY, Jaufeerally F, Ng TP, Troughton R, Doughty RN, Passino C, Emdin M.

Eur J Heart Fail. 2020 Jan 9. doi: 10.1002/ejhf.1701. [Epub ahead of print]

PMID:
31919929
25.

Global Differences in Characteristics, Precipitants, and Initial Management of Patients Presenting With Acute Heart Failure.

Filippatos G, Angermann CE, Cleland JGF, Lam CSP, Dahlström U, Dickstein K, Ertl G, Hassanein M, Hart KW, Lindsell CJ, Perrone SV, Guerin T, Ghadanfar M, Schweizer A, Obergfell A, Collins SP.

JAMA Cardiol. 2020 Jan 8. doi: 10.1001/jamacardio.2019.5108. [Epub ahead of print]

PMID:
31913404
26.

Seipin Knockout Mice Develop Heart Failure With Preserved Ejection Fraction.

Bai B, Yang W, Fu Y, Foon HL, Tay WT, Yang K, Luo C, Gunaratne J, Lee P, Zile MR, Xu A, Chin CWL, Lam CSP, Han W, Wang Y.

JACC Basic Transl Sci. 2019 Nov 20;4(8):924-937. doi: 10.1016/j.jacbts.2019.07.008. eCollection 2019 Dec.

27.

Interdependence of Atrial Fibrillation and Heart Failure With a Preserved Ejection Fraction Reflects a Common Underlying Atrial and Ventricular Myopathy.

Packer M, Lam CSP, Lund LH, Redfield MM.

Circulation. 2020 Jan 7;141(1):4-6. doi: 10.1161/CIRCULATIONAHA.119.042996. Epub 2019 Dec 30. No abstract available.

PMID:
31887078
28.

Regional Variation of Mortality in Heart Failure With Reduced and Preserved Ejection Fraction Across Asia: Outcomes in the ASIAN-HF Registry.

MacDonald MR, Tay WT, Teng TK, Anand I, Ling LH, Yap J, Tromp J, Wander GS, Naik A, Ngarmukos T, Siswanto BB, Hung CL, Richards AM, Lam CSP; ASIAN‐F investigators †; ASIAN‐F investigators <xref ref-type="author-note" rid="jah34461-note-1001"><sup>†</sup></xref>.

J Am Heart Assoc. 2020 Jan 7;9(1):e012199. doi: 10.1161/JAHA.119.012199. Epub 2019 Dec 19. Erratum in: J Am Heart Assoc. 2020 Mar 3;9(5):e014512.

29.

A porcine model of heart failure with preserved ejection fraction: magnetic resonance imaging and metabolic energetics.

Charles CJ, Lee P, Li RR, Yeung T, Ibraham Mazlan SM, Tay ZW, Abdurrachim D, Teo XQ, Wang WH, de Kleijn DPV, Cozzone PJ, Lam CSP, Richards AM.

ESC Heart Fail. 2020 Feb;7(1):92-102. doi: 10.1002/ehf2.12536. Epub 2019 Dec 18.

30.

Potassium abnormalities in patients with heart failure from 11 Asian regions: insights from the ASIAN-HF registry.

Beusekamp JC, Teng TK, Tay WT, Ouwerkerk W, Richards AM, Anand IS, Chopra VK, Wander GS, van der Meer P, Voors AA, Lam CSP, Tromp J.

Eur J Heart Fail. 2019 Dec 18. doi: 10.1002/ejhf.1640. [Epub ahead of print] No abstract available.

PMID:
31851416
31.

Association between body surface area and prescribed doses of guideline-directed medications among international patients with heart failure and reduced ejection fraction.

Teng TK, Cooper L, Tay WT, Luo N, Sharma A, Whellan D, Anand I, Pina IL, Tromp J, Richards AM, Kraus WE, Connor CMO, Mentz RJ, Lam CSP.

Eur J Heart Fail. 2019 Dec 18. doi: 10.1002/ejhf.1648. [Epub ahead of print] No abstract available.

PMID:
31849161
32.

International Consortium for Health Outcomes Measurement (ICHOM): Standardized Patient-Centered Outcomes Measurement Set for Heart Failure Patients.

Burns DJP, Arora J, Okunade O, Beltrame JF, Bernardez-Pereira S, Crespo-Leiro MG, Filippatos GS, Hardman S, Hoes AW, Hutchison S, Jessup M, Kinsella T, Knapton M, Lam CSP, Masoudi FA, McIntyre H, Mindham R, Morgan L, Otterspoor L, Parker V, Persson HE, Pinnock C, Reid CM, Riley J, Stevenson LW, McDonagh TA.

JACC Heart Fail. 2020 Mar;8(3):212-222. doi: 10.1016/j.jchf.2019.09.007. Epub 2019 Dec 11. Review.

33.

Baseline features of the VICTORIA (Vericiguat Global Study in Subjects with Heart Failure with Reduced Ejection Fraction) trial.

Pieske B, Patel MJ, Westerhout CM, Anstrom KJ, Butler J, Ezekowitz J, Hernandez AF, Koglin J, Lam CSP, Ponikowski P, Roessig L, Voors AA, O'Connor CM, Armstrong PW; VICTORIA Study Group.

Eur J Heart Fail. 2019 Dec;21(12):1596-1604. doi: 10.1002/ejhf.1664. Epub 2019 Dec 9.

PMID:
31820546
34.

Assessing the evidence-practice gap for heart failure in China: the Heart Failure Registry of Patient Outcomes (HERO) study design and baseline characteristics.

Li L, Liu R, Jiang C, Du X, Huffman MD, Lam CSP, Patel A, Hillis GS, Anderson CS, Ma C, Zhao X, Wang X, Li L, Dong J.

Eur J Heart Fail. 2019 Dec 9. doi: 10.1002/ejhf.1630. [Epub ahead of print]

PMID:
31820513
35.

Echocardiographic Features of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.

Shah AM, Cikes M, Prasad N, Li G, Getchevski S, Claggett B, Rizkala A, Lukashevich I, O'Meara E, Ryan JJ, Shah SJ, Mullens W, Zile MR, Lam CSP, McMurray JJV, Solomon SD; PARAGON-HF Investigators.

J Am Coll Cardiol. 2019 Dec 10;74(23):2858-2873. doi: 10.1016/j.jacc.2019.09.063.

PMID:
31806129
36.

Sex differences in heart failure.

Lam CSP, Arnott C, Beale AL, Chandramouli C, Hilfiker-Kleiner D, Kaye DM, Ky B, Santema BT, Sliwa K, Voors AA.

Eur Heart J. 2019 Dec 14;40(47):3859-3868c. doi: 10.1093/eurheartj/ehz835.

PMID:
31800034
37.

Harnessing technology and molecular analysis to understand the development of cardiovascular diseases in Asia: a prospective cohort study (SingHEART).

Yap J, Lim WK, Sahlén A, Chin CW, Chew KMY, Davila S, Allen J, Goh V, Tan SY, Tan P, Lam CSP, Cook SA, Yeo KK.

BMC Cardiovasc Disord. 2019 Nov 21;19(1):259. doi: 10.1186/s12872-019-1248-3.

38.

Effects of Sacubitril-Valsartan Versus Valsartan in Women Compared With Men With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF.

McMurray JJV, Jackson AM, Lam CSP, Redfield MM, Anand IS, Ge J, Lefkowitz MP, Maggioni AP, Martinez F, Packer M, Pfeffer MA, Pieske B, Rizkala AR, Sabarwal SV, Shah AM, Shah SJ, Shi VC, van Veldhuisen DJ, Zannad F, Zile MR, Cikes M, Goncalvesova E, Katova T, Kosztin A, Lelonek M, Sweitzer N, Vardeny O, Claggett B, Jhund PS, Solomon SD.

Circulation. 2020 Feb 4;141(5):338-351. doi: 10.1161/CIRCULATIONAHA.119.044491. Epub 2019 Nov 17.

PMID:
31736337
39.

Concentric vs. eccentric remodelling in heart failure with reduced ejection fraction: clinical characteristics, pathophysiology and response to treatment.

Nauta JF, Hummel YM, Tromp J, Ouwerkerk W, van der Meer P, Jin X, Lam CSP, Bax JJ, Metra M, Samani NJ, Ponikowski P, Dickstein K, Anker SD, Lang CC, Ng LL, Zannad F, Filippatos GS, van Veldhuisen DJ, van Melle JP, Voors AA.

Eur J Heart Fail. 2019 Nov 11. doi: 10.1002/ejhf.1632. [Epub ahead of print]

PMID:
31713324
40.

Assessment of Predictors of Left Atrial Volume Response to a Transcatheter InterAtrial Shunt Device (from the REDUCE LAP-HF Trial).

Hanff TC, Kaye DM, Hayward CS, Post MC, Malek F, Hasenfuβ G, Gustafsson F, Burkhoff D, Shah SJ, Litwin SE, Kahwash R, Hummel SL, Borlaug BA, Solomon SD, Lam CSP, Komtebedde J, Silvestry FE; REDUCE LAP-HF study investigators, and research staff.

Am J Cardiol. 2019 Dec 15;124(12):1912-1917. doi: 10.1016/j.amjcard.2019.09.019. Epub 2019 Sep 26.

PMID:
31653352
41.

Identification of a Novel Betacoronavirus (Merbecovirus) in Amur Hedgehogs from China.

Lau SKP, Luk HKH, Wong ACP, Fan RYY, Lam CSF, Li KSM, Ahmed SS, Chow FWN, Cai JP, Zhu X, Chan JFW, Lau TCK, Cao K, Li M, Woo PCY, Yuen KY.

Viruses. 2019 Oct 24;11(11). pii: E980. doi: 10.3390/v11110980.

42.

Reply in response to 'Defining a "frequent admitter" phenotype among patients with repeat heart failure admissions'.

Go YY, Allen JC Jr, Lam CSP.

Eur J Heart Fail. 2020 Feb;22(2):385-386. doi: 10.1002/ejhf.1622. Epub 2019 Oct 21. No abstract available.

PMID:
31637824
43.

Comparison of open-ended and close-ended questions to determine signs and symptoms of eye problems among children.

Chen AH, Bakar NA, Lam CS.

J Optom. 2019 Oct 16. pii: S1888-4296(19)30069-X. doi: 10.1016/j.optom.2019.07.002. [Epub ahead of print]

44.

Large-Scale Whole-Genome Sequencing of Three Diverse Asian Populations in Singapore.

Wu D, Dou J, Chai X, Bellis C, Wilm A, Shih CC, Soon WWJ, Bertin N, Lin CB, Khor CC, DeGiorgio M, Cheng S, Bao L, Karnani N, Hwang WYK, Davila S, Tan P, Shabbir A, Moh A, Tan EK, Foo JN, Goh LL, Leong KP, Foo RSY, Lam CSP, Richards AM, Cheng CY, Aung T, Wong TY, Ng HH; SG10K Consortium, Liu J, Wang C.

Cell. 2019 Oct 17;179(3):736-749.e15. doi: 10.1016/j.cell.2019.09.019.

PMID:
31626772
45.

Biomarker Correlates of Coronary Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction.

Tromp J, Hage C, Ouwerkerk W, Sanders-van Wijk S, Svedlund S, Saraste A, Ljung Faxén U, Lagerstrom Fermer M, Gan LM, Lund LH, Shah SJ, Lam CSP.

Circulation. 2019 Oct 15;140(16):1359-1361. doi: 10.1161/CIRCULATIONAHA.119.042569. Epub 2019 Oct 14. No abstract available.

PMID:
31609659
46.

SGLT-2 Inhibitors in Heart Failure: Current Management, Unmet Needs, and Therapeutic Prospects.

Lam CSP, Chandramouli C, Ahooja V, Verma S.

J Am Heart Assoc. 2019 Oct 15;8(20):e013389. doi: 10.1161/JAHA.119.013389. Epub 2019 Oct 12. No abstract available.

47.

Accidental Spill of Palm Stearin Poses Relatively Short-Term Ecological Risks to a Tropical Coastal Marine Ecosystem.

Zhou GJ, Lai RWS, Sham RC, Lam CS, Yeung KWY, Astudillo JC, Ho KKY, Yung MMN, Yau JKC, Leung KMY.

Environ Sci Technol. 2019 Nov 5;53(21):12269-12277. doi: 10.1021/acs.est.9b04636. Epub 2019 Oct 10.

PMID:
31556997
48.

Association of obesity with heart failure outcomes in 11 Asian regions: A cohort study.

Chandramouli C, Tay WT, Bamadhaj NS, Tromp J, Teng TK, Yap JJL, MacDonald MR, Hung CL, Streng K, Naik A, Wander GS, Sawhney J, Ling LH, Richards AM, Anand I, Voors AA, Lam CSP; ASIAN-HF Investigators.

PLoS Med. 2019 Sep 24;16(9):e1002916. doi: 10.1371/journal.pmed.1002916. eCollection 2019 Sep.

49.

How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC).

Pieske B, Tschöpe C, de Boer RA, Fraser AG, Anker SD, Donal E, Edelmann F, Fu M, Guazzi M, Lam CSP, Lancellotti P, Melenovsky V, Morris DA, Nagel E, Pieske-Kraigher E, Ponikowski P, Solomon SD, Vasan RS, Rutten FH, Voors AA, Ruschitzka F, Paulus WJ, Seferovic P, Filippatos G.

Eur Heart J. 2019 Oct 21;40(40):3297-3317. doi: 10.1093/eurheartj/ehz641.

PMID:
31504452
50.

Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction.

Solomon SD, McMurray JJV, Anand IS, Ge J, Lam CSP, Maggioni AP, Martinez F, Packer M, Pfeffer MA, Pieske B, Redfield MM, Rouleau JL, van Veldhuisen DJ, Zannad F, Zile MR, Desai AS, Claggett B, Jhund PS, Boytsov SA, Comin-Colet J, Cleland J, Düngen HD, Goncalvesova E, Katova T, Kerr Saraiva JF, Lelonek M, Merkely B, Senni M, Shah SJ, Zhou J, Rizkala AR, Gong J, Shi VC, Lefkowitz MP; PARAGON-HF Investigators and Committees.

N Engl J Med. 2019 Oct 24;381(17):1609-1620. doi: 10.1056/NEJMoa1908655. Epub 2019 Sep 1.

PMID:
31475794

Supplemental Content

Support Center